Evaluation of LIH383 as a new neuro-pharmacological modulator.

SCHEME: PATHFINDER

CALL: 2018

DOMAIN: BM - Life Sciences, Biology and Medicine

FIRST NAME: Andy

LAST NAME: Chevigne

INDUSTRY PARTNERSHIP / PPP: No

INDUSTRY / PPP PARTNER:

HOST INSTITUTION: LIH

KEYWORDS: Pharmacology, brain, chemokine receptor, immunology, neurosciences, drug discovery, medical chemistry

START: 2019-01-01

END: 2020-03-31

WEBSITE: https://www.lih.lu